KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Novartis Ag (NVS) over the last 6 years, with Q1 2025 value amounting to -$172.0 million.

  • Novartis Ag's Change in Account Payables rose 5794.62% to -$172.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$236.0 million, marking a year-over-year decrease of 15652.17%. This contributed to the annual value of -$297.0 million for FY2024, which is 2857.14% down from last year.
  • Per Novartis Ag's latest filing, its Change in Account Payables stood at -$172.0 million for Q1 2025, which was up 5794.62% from -$297.0 million recorded in Q4 2024.
  • In the past 5 years, Novartis Ag's Change in Account Payables registered a high of $87.0 million during Q1 2023, and its lowest value of -$409.0 million during Q1 2024.
  • Its 5-year average for Change in Account Payables is -$139.5 million, with a median of -$68.0 million in 2022.
  • Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 216666.67% in 2022, then skyrocketed by 22985.07% in 2023.
  • Quarter analysis of 5 years shows Novartis Ag's Change in Account Payables stood at -$4.0 million in 2021, then tumbled by 1575.0% to -$67.0 million in 2022, then plummeted by 244.78% to -$231.0 million in 2023, then fell by 28.57% to -$297.0 million in 2024, then skyrocketed by 42.09% to -$172.0 million in 2025.
  • Its last three reported values are -$172.0 million in Q1 2025, -$297.0 million for Q4 2024, and -$290.0 million during Q3 2024.